Rosalind Advisors, Inc.

Position in XERS — Xeris Biopharma Holdings, Inc.

CIK 1622627 TORONTO, A6

Position in XERS

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$23,039,129

+$4,295,269 QoQ

Shares Held

2,908,981

-10.0% QoQ

Ownership

1.60%

of shares outstanding

% of Portfolio

8.63%

of 13F equity value

Holder Rank

of 238 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Rosalind Advisors, Inc. holds $37,825,481 across 5 Drug Manufacturers - Specialty & Generic names. XERS ranks #1 (60.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	XERS	Xeris Biopharma Holdings, Inc. This page	2,908,981	$23,039,129
2	BCRX	Biocryst Pharmaceuticals Inc	721,504	$7,215,040
3	TLPH	Talphera, Inc.	5,169,501	$5,324,586
4	BFRI	Biofrontera Inc.	1,275,609	$1,206,726
5	AQST	Aquestive Therapeutics, Inc.	250,000	$1,040,000

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$23,039,129	2,908,981	-10.0%	Shares	Sole	2026-08-14
2026-03-31	$18,743,860	3,231,700	+53.0%	Shares	Sole	2026-05-14
2025-12-31	$16,576,845	2,111,700	+17.6%	Shares	Sole	2026-02-12
2025-09-30	$14,617,535	1,795,766	-16.7%	Shares	Sole	2025-11-13
2025-06-30	$10,066,623	2,155,594	-13.6%	Shares	Sole	2025-08-14
2025-03-31	$13,702,963	2,495,986	-19.6%	Shares	Sole	2025-05-14
2024-12-31	$10,525,933	3,104,995	0.0%	Shares	Sole	2025-02-14
2024-09-30	$8,849,235	3,104,995	-0.5%	Shares	Sole	2024-10-30
2024-06-30	$7,020,382	3,120,170	+10.6%	Shares	Sole	2024-07-12
2024-03-31	$6,232,575	2,820,170	-20.4%	Shares	Sole	2024-04-25
2023-12-31	$8,327,659	3,543,685	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.